… breast cancer (1), and we have developed an HER2 peptide-pulsed dendritic cell (DC1)
vaccine that … with prostate cancer, 8.5% in patients with melanoma, 11.5% in patients with renal …

… , it was demonstrated that one in every four to five patients with melanoma, renal cell carcinoma…
Dendritic cell (DC) vaccines are most frequently created by pulsing DCs with autologous …

… ) carried out preclinical studies on murine colorectal tumor by combining … Vaccination of
pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells …

… , dendritic cell based vaccines and autologous tumour cell … with recurrent or metastatic
colorectal cancer (mCRC) still have … -administered to patients with metastatic melanoma promoted …

… vaccinated with autologous tumor lysate pulsed dendritic … of adoptive T cell transfer and
dendritic cell vaccine combination … Although this study predominately studied colorectal cancer, a …

… Thus in this review, according to the previous studies, we … On the basis of those studies,
DEX vaccine researches have … Moreover, phase I clinical trials in melanoma and advanced …

… In clinical cases of advanced-stage melanoma, current … ; 2) hepatocellular carcinoma
patients that have previously … for metastatic colorectal cancer in adult or paediatric patients with …

… -H) colorectal cancer (CRC), while pancreatic cancer (PC) … T-cell responses more potent
than cancer cell lysate- pulsed … tumor lysate-loaded DC vaccine with ex vivo activated T-cell …

… Tumor size and injection modes were not analyzed in this article because of insufficient …
Study on DC-CIK cells combined with intravenous chemotherapy for advanced colorectal cancer …

… is introduced: carrier protein, cells (for example, dendritic cells (DCs)), … , a study in patients
with colorectal cancer vaccinated with … tumor lysate-pulsed DCs, a randomized phase II trial …